Abstract
Methods: Thirty six patients with COPD (II=13, ID=11, DD=12) received oral captopril (25 mg) or placebo in a randomised, double blind, crossover manner and underwent right heart catheterisation with exercise.
Results: Mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and lactate concentration after exercise with both placebo and captopril were higher in patients with the DD genotype than in those with the II or ID genotypes. In contrast, mixed venous oxygen tension (PvO2) was lower in patients with the DD genotype than in those with the other genotypes. Moreover, mPAP, PVR, and lactate concentration after exercise were lower in the captopril group than in the placebo group in patients with the II or ID genotype, but not in those with the DD genotype. PvO2 after exercise was higher with captopril than with placebo in patients with the II genotype, but not in those with the other genotypes.
Conclusions: These findings suggest that pulmonary haemodynamic variables and state of tissue oxygenation during exercise are dependent on ACE genotypes, and that captopril administration effectively influences these exercise related variables. Although the sample size in this pilot study was limited, it is likely that the improvement in exercise related variables in COPD patients with the II genotype is relatively sensitive to captopril.
Full Text
The Full Text of this article is available as a PDF (98.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertoli L., Lo Cicero S., Busnardo I., Rizzato G., Montanari G. Effects of captopril on hemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension. Respiration. 1986;49(4):251–256. doi: 10.1159/000194887. [DOI] [PubMed] [Google Scholar]
- Fukuoka Yoshiyuki, Grassi Bruno, Conti Marco, Guiducci Daniela, Sutti Monica, Marconi Claudio, Cerretelli Paolo. Early effects of exercise training on on- and off-kinetics in 50-year-old subjects. Pflugers Arch. 2001 Nov 7;443(5-6):690–697. doi: 10.1007/s00424-001-0748-y. [DOI] [PubMed] [Google Scholar]
- Kanazawa H., Okamoto T., Hirata K., Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1235–1238. doi: 10.1164/ajrccm.162.4.9909120. [DOI] [PubMed] [Google Scholar]
- Kanazawa Hiroshi, Otsuka Toshihiro, Hirata Kazuto, Yoshikawa Junichi. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest. 2002 Mar;121(3):697–701. doi: 10.1378/chest.121.3.697. [DOI] [PubMed] [Google Scholar]
- Puente-Maestu L., Sánz M. L., Sánz P., Nuñez A., González F., Whipp B. J. Reproducibility of the parameters of the on-transient cardiopulmonary responses during moderate exercise in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol. 2001 Sep;85(5):434–441. doi: 10.1007/s004210100486. [DOI] [PubMed] [Google Scholar]
- Rich S., Kaufmann E., Levy P. S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992 Jul 9;327(2):76–81. doi: 10.1056/NEJM199207093270203. [DOI] [PubMed] [Google Scholar]
- Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992 Mar 25;20(6):1433–1433. doi: 10.1093/nar/20.6.1433-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ueda S., Heeley R. P., Lees K. R., Elliott H. L., Connell J. M. Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. J Mol Endocrinol. 1996 Aug;17(1):27–30. doi: 10.1677/jme.0.0170027. [DOI] [PubMed] [Google Scholar]